Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL) June 20, 2024 This content is password-protected. To view it, please enter the password below. Password:
Cancer Drug News FDA approves selpercatinib for RET fusion-positive thyroid cancer June 19, 2024 On June 12, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo,…
Cancer Drug News Access to targeted lung cancer drug durvalumab is cost-prohibitive globally June 5, 2024 Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses…
Cancer Drug News FDA grants accelerated approval to selpercatinib for paediatric patients two years and older with RET-altered metastatic thyroid cancer or solid tumours June 4, 2024 On May 29, 2024, the Food and Drug Administration granted accelerated approval to selpercatinib (Retevmo,…
FDA Approvals FDA approves lisocabtagene maraleucel for relapsed or refractory mantle cell lymphoma June 4, 2024 On May 30, 2024, the US Food and Drug Administration approved lisocabtagene maraleucel (Breyanzi, Juno…
Cancer Drug News Recent FDA committee vote could speed multiple myeloma drug approval May 29, 2024 A U.S. Food and Drug Administration committee voted unanimously in April to approve a new…
Cancer Drug News Integration of pharmacies with physician practices has little impact on cancer drug expenditures May 29, 2024 Integration of pharmacies with physician practices, where on-site pharmacies open at physician practice locations, is…
Cancer Drug News New study further illuminates ability of cancer drug to lower blood sugar May 29, 2024 University of Oklahoma researchers in the USA have deepened their understanding of a drug’s ability…
Cancer Drug News Scientists uncover promising treatment target for resistant glioblastoma May 25, 2024 For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is…
Cancer Drug News FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer May 10, 2024 On April 29, 2024, the Food and Drug Administration granted traditional approval to tisotumab vedotin-tftv…